AIM2 and cancer: Exogenous IL-1β stimulated proliferation of TRAMPC2 cancer cells, and addition of exogenous IL-1β stimulated proliferation of TRAMPC2 cancer cells similarly in the presence of WT and AIM2-/- or Caspase1/11-/- macrophages (Figure 4A).